© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
Pfizer Inc. has ended its research into sildenafil citrate (Viagra) as a treatment for female sexual arousal disorder (FSAD) after several large studies showed inconclusive efficacy.